Share Prices & Company Research

Stockbroking

Arix Bioscience

Current Price 111.50p Bid 110.00p Ask 115.00p Change 0.00%
Last Updated: 12/12/2019 12:07. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. It collaborates with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, it is able to bring this exciting growth phase of our industry to a broader range of investors.

Financial Highlights Year Ended 31/12/2018

Turnover
£1.33m
Operating Profit
£40.80m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
3.51

Key Personnel

Dr Joseph Anderson
Chief Executive Officer
Jonathan Peacock
Non-Executive Chairman
Arthur Menelaus Pappas
Non-Executive Director
Giles Francis Bertram Kerr
Non-Executive Director
Prof Trevor Mervyn Jones
Non-Executive Director
Dr Franz Bernard Humer
Non-Executive Director
Mark Andrew Breuer
Non-Executive Director

Stock Details

EPIC
ARIX
ISIN
GB00BD045071
Shares in Issue
135,551,850
Market cap
£152.50m

Analyst Views (1)

Strong Buy
 
100.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
112.50p
Bid Price
110.00p
Ask Price
115.00p
Volume
14658
Change Today
0.00p
% Change Today
0.00%
Open
111.00p
Previous Close
112.50p
Intraday High
115.00p
Intraday Low
111.00p
52 Week High
175.00p
52 Week Low
102.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Arix Bioscience Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Tangible Assets
0.3
0.5
Intangible Assets & Goodwill
1.8
2.1
Investments & Other Non-Current Assets
184.0
71.3
Total Non-Current Assets
186.1
73.9
Inventory
0.0
0.0
Trade & Receivables
2.2
1.3
Cash & Receivables
31.0
74.9
Other Current Assets & Assets Held for Resale
60.2
0.0
Total Assets
279.5
150.1

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Short Term Liabilities
9.3
3.7
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
9.3
3.7

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Net Assets
270.2
146.5

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Share Capital
188.6
105.1
Minority Interests
0.0
0.0
Retained Earnings
82.0
42.1
Share Premium Account
0.0
0.0
Other Equity
-0.4
-0.8
Total Equity
270.2
146.5

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Cashflow from Operating Activities
-11.1
-8.8
Cashflow Before Financing
-126.5
-59.0
Increase / Decrease in Cash
-44.3
46.1

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Dec 2018
31 Dec 2017
Turnover
1.3
1.9
Cost of Sales
0.0
0.0
Gross Profit
0.0
0.0
Operating Profit
40.8
-3.6
Pre-Tax Profit
42.8
-7.7
Profit / Loss for the Year
36.9
-7.5
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.